| # | Title | Journal | Year | Citations |
|---|
| 1 | Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Cytotherapy | 2006 | 13,839 |
| 2 | Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance | Clinical Microbiology and Infection | 2012 | 8,996 |
| 3 | Inflammation, Atherosclerosis, and Coronary Artery Disease | New England Journal of Medicine | 2005 | 7,433 |
| 4 | Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol | Lancet, The | 2002 | 4,917 |
| 5 | HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis | Pediatric Blood and Cancer | 2007 | 4,018 |
| 6 | The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes | Blood | 2009 | 3,864 |
| 7 | Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus | Arthritis and Rheumatism | 2012 | 3,838 |
| 8 | Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients | Journal of Thrombosis and Haemostasis | 2005 | 3,778 |
| 9 | External review and validation of the Swedish national inpatient register | BMC Public Health | 2011 | 3,713 |
| 10 | Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial | Lancet, The | 2003 | 3,420 |
| 11 | International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma | Lancet Oncology, The | 2014 | 3,343 |
| 12 | Progress and challenges in translating the biology of atherosclerosis | Nature | 2011 | 3,058 |
| 13 | Neural systems supporting interoceptive awareness | Nature Neuroscience | 2004 | 2,955 |
| 14 | Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study | Lancet, The | 2001 | 2,914 |
| 15 | Fears, phobias, and preparedness: Toward an evolved module of fear and fear learning. | Psychological Review | 2001 | 2,694 |
| 16 | Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial | Lancet, The | 2005 | 2,662 |
| 17 | The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After | Surgery | 2017 | 2,655 |
| 18 | Discovery and refinement of loci associated with lipid levels | Nature Genetics | 2013 | 2,641 |
| 19 | Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial | Lancet, The | 2003 | 2,584 |
| 20 | Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study | Lancet, The | 2007 | 2,527 |
| 21 | Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study | Lancet Infectious Diseases, The | 2010 | 2,485 |
| 22 | Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study | Lancet, The | 2008 | 2,474 |
| 23 | Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study | Lancet Oncology, The | 2009 | 2,404 |
| 24 | Premature ageing in mice expressing defective mitochondrial DNA polymerase | Nature | 2004 | 2,318 |
| 25 | Characterization of a New Metallo-β-Lactamase Gene, bla NDM-1 , and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India | Antimicrobial Agents and Chemotherapy | 2009 | 2,065 |
| 26 | Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary non-polyposis colon cancer | Nature | 1994 | 2,001 |
| 27 | Limb proportions show developmental plasticity in response to embryo movement | Scientific Reports | 2017 | 1,989 |
| 28 | Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial | Lancet, The | 2003 | 1,978 |
| 29 | Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene | Nature | 1995 | 1,977 |
| 30 | Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview | Lancet, The | 2000 | 1,959 |
| 31 | Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial | Lancet, The | 1999 | 1,938 |
| 32 | Dynamics of fat cell turnover in humans | Nature | 2008 | 1,914 |
| 33 | GRADE guidelines 6. Rating the quality of evidence—imprecision | Journal of Clinical Epidemiology | 2011 | 1,907 |
| 34 | A survey of best practices for RNA-seq data analysis | Genome Biology | 2016 | 1,898 |
| 35 | The immune response in atherosclerosis: a double-edged sword | Nature Reviews Immunology | 2006 | 1,890 |
| 36 | EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update | Annals of the Rheumatic Diseases | 2020 | 1,860 |
| 37 | CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group | Lancet Oncology, The | 2006 | 1,840 |
| 38 | Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003 | Journal of Allergy and Clinical Immunology | 2004 | 1,836 |
| 39 | Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2 | Cell | 2020 | 1,827 |
| 40 | Hundreds of variants clustered in genomic loci and biological pathways affect human height | Nature | 2010 | 1,789 |
| 41 | Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme | Lancet, The | 2003 | 1,752 |
| 42 | Inflammation in Atherosclerosis | Journal of the American College of Cardiology | 2009 | 1,738 |
| 43 | The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research | European Journal of Epidemiology | 2009 | 1,722 |
| 44 | Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up | Hepatology | 2015 | 1,683 |
| 45 | The Manual Ability Classification System (MACS) for children with cerebral palsy: scale development and evidence of validity and reliability | Developmental Medicine and Child Neurology | 2006 | 1,679 |
| 46 | Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement | Cytotherapy | 2005 | 1,661 |
| 47 | Conscious and unconscious emotional learning in the human amygdala | Nature | 1998 | 1,630 |
| 48 | Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma | JAMA - Journal of the American Medical Association | 2017 | 1,619 |
| 49 | Atherosclerosis | Nature Reviews Disease Primers | 2019 | 1,601 |
| 50 | Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19 | Cell | 2020 | 1,561 |
